Euromed Milk Thistle Extract Investigated As A Treatment For COVID-19
Monday, July 20th, 2020 | 1840 Views
The Spanish Agency for Medicines and Health Products (AEMPS) has approved the clinical trial SilCOVID19 with this substance in oncohematological patients with coronavirus. Euromed S.A. manufactures standardised botanical extracts, and its milk thistle extract has been clinically studied during the past few decades in thousands of patients worldwide.
Milk thistle (Silybum marianum) is a herbaceous plant that’s usually adorned with a purple-pink flower. Milk thistle seed extracts have validated benefits for liver health. They also have been used both preventively and curatively to protect the liver from toxins, including alcohol, aspirin, acetaminophen, heavy metals and the death cap mushroom.
The active constituent of milk thistle seeds (fruits) is a flavonoid called silymarin, the key component of which is silibinin. Recent investigation suggests that it may have further benefits that go beyond liver support. For instance, silibinin has a recognised antitumor activity, and could also be effective in the fight against COVID-19.
According to this study by the Catalan Institute of Oncology (ICO) and the Girona Biomedical Research Institute (IDIBGI), silibinin acts as an immunodulator and antiviral for oncohematological patients with COVID-19. Hence this natural molecule has the potential for use in the fight against COVID-19.
Check these articles out: